1. Home
  2. ATEN vs AMPH Comparison

ATEN vs AMPH Comparison

Compare ATEN & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo A10 Networks Inc.

ATEN

A10 Networks Inc.

N/A

Current Price

$20.39

Market Cap

1.2B

Sector

Technology

ML Signal

N/A

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

N/A

Current Price

$18.95

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ATEN
AMPH
Founded
2004
1996
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2014
2005

Fundamental Metrics

Financial Performance
Metric
ATEN
AMPH
Price
$20.39
$18.95
Analyst Decision
Strong Buy
Buy
Analyst Count
4
7
Target Price
$23.75
$30.29
AVG Volume (30 Days)
760.5K
499.1K
Earning Date
05-04-2026
06-01-2026
Dividend Yield
1.17%
N/A
EPS Growth
N/A
N/A
EPS
0.57
2.03
Revenue
$235,429,000.00
$719,887,000.00
Revenue This Year
$12.96
$7.34
Revenue Next Year
$10.18
$4.81
P/E Ratio
$35.82
$9.54
Revenue Growth
2.36
N/A
52 Week Low
$13.81
$18.94
52 Week High
$21.31
$31.26

Technical Indicators

Market Signals
Indicator
ATEN
AMPH
Relative Strength Index (RSI) 58.46 24.09
Support Level $17.04 N/A
Resistance Level $21.31 $28.56
Average True Range (ATR) 0.64 1.19
MACD 0.02 -0.89
Stochastic Oscillator 72.00 3.08

Price Performance

Historical Comparison
ATEN
AMPH

About ATEN A10 Networks Inc.

A10 Networks Inc is a provider of security and infrastructure solutions for on-premises, hybrid cloud, and edge-cloud environments of its multinational enterprise, communication, cloud and web service provider customers who strive to provide business-critical applications and networks that are secure, available, and efficient. As cyber-attacks increase in volume and complexity, the company integrates security and artificial intelligence (AI) enabled capabilities in its solutions that enable its customers to continue to adapt to market trends in hybrid cloud, AI-ready data centers and the ever-increasing need for high-performance, high availability and low latency. The company generates the maximum of its revenue from Americas.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: